$7.8 Million Risperdal Settlement Reached With State of Arkansas
According to a Bloomberg Business article, Johnson & Johnson (J&J) will pay $7.8 million to settle the state of Arkansas’s claims that it illegally marketed Risperdal, an antipsychotic […]